TCL Archive Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response December 28, 2012
TCL Archive In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm January 31, 1986